Objective: To explore whether there were any changes in the maternal risk factors of congenital heart disease (CHD) in Chinese population between the ten years before 2008 (1999-2008) and the ten years after 2008 (2009-2018).
Introduction
Congenital heart disease (CHD) is one of the most common birth defects and one of the leading causes of infant death worldwide [1] [2] [3] . Although great advances in the surgical and medical treatment of CHD have led to a remarkable improvement in the survival rate of CHD neonates, due to the existence of complications such as heart failure, arrhythmia and pulmonary arterial hypertension, the life quality of CHD patients is still poorer and the mortality is much higher compared to general population, which exerts huge medical expenditures for both family and society [4, 5] . Obviously, the best solution towards this situation is to prevent CHD from happening. Therefore, to identify the risk factors of CHD, especially the modifiable factors such as maternal risk factors, and take corresponding measures is of 
Methods

Literature selection
Literature selection was conducted in PubMed, Web of Science, China National Knowledge Infrastructure, Chinese Scientific and Technological Journal Database, China Biology Medicine disc and Wanfang Data to collect all Chinese and English relevant studies published in the ten years before 2008 and the ten years after 2008. The search strategy was as follows: ("congenital heart disease*" OR "congenital heart defect*" OR "heart abnormalit*" OR "malformation of heart" OR "congenital cardiovascular disease*" OR "CHD") AND ("risk" OR"etiology" OR "onset" OR "association" OR "connection" OR "relationship") AND ("Chinese" OR "China"). In addition, reference lists of the related original and review articles were checked manually to find additional studies that may meet the eligibility criteria. Literature selection was performed by two authors independently.
Eligibility Criteria
Eligible studies had to meet all of the following criteria: (1) relevant to the maternal risk factors of CHD in Chinese population; (2) were original epidemiological studies (i.e., case-control, cohort or RCT); (3) reported effect estimates and their 95% confidence intervals (CI), or provided sufficient data from which these measures could be calculated; (4) published in English or Chinese language. Studies was excluded if they: (1) were animal studies; (2) were of poor quality; (3) contained overlapped data; (4) reported incomplete data that cannot be obtained after contact with the author. Titles and abstracts of retrieved studies were screened according to the above criteria by two authors independently, then full text of any potential relevant articles were assessed rigorously. Disagreements were resolved by discussion with the third author.
Data extraction
Data extraction was performed by two authors separately, and discrepancies were resolved by discussion with the third author. The following data were extracted from each eligible study: first author, geographical region, year of publication, study design, sample size, maternal risk factors and their adjusted estimates and corresponding 95% CI. If no effect estimate was provided in a given study, odds ratio (OR) or risk ratio (RR) and 95% CI would be calculated from the raw data presented in the study. And the authors would be contacted for further information if necessary.
Quality assessment
The quality of the eligible studies were assessed by the 9-star Newcastle-Ottawa Scale (NOS), which evaluates a study based on three major aspects: selection, comparability, and exposure or outcome [6] . Quality assessment was performed by two authors independently. If differences of opinion arose, these would be settled by discussion with the third author.
Statistical analysis
Where maternal risk factors had consistent definitions across studies (at least 3 studies) and effect estimates were presented in a similar fashion, meta-analysis would be performed to calculate the pooled OR and corresponding 95%
CI. Cochran's Q and I 2 statistics were calculated to test for the heterogeneity among studies. If no evidence of heterogeneity was presented (p>0.1, I 2 <50%), a fixed effect model would be used. Otherwise, a random effect model would be adopted, and meta regression analyses would be further conducted based on year of publication, quality of study, geographical region and number of cases to explore the source of heterogeneity. Meta regression analyses would be conducted only when there were no fewer than 10 studies. Then subgroup analyses were performed based on the potential sources of heterogeneity. Sensitivity analysis was performed by omitting one study at a time to determine whether the results of meta-analysis were stable. Publication bias would be conducted only when there were no fewer than 10 studies, via Egger's linear regression method. Probability value P<0.05 was considered statistically significant.
All statistical analyses were performed using STATA software (version 14.0; Stata Corporation, College Station, Texas, USA).
Results
Literature selection
A total of 4686 studies were obtained initially, of which 4508 studies were obtained through database searching, 178 studies were obtained by reference lists checking. After the duplicate studies were removed, titles and abstracts of the remaining 2516 studies were further screened for eligibility. Full text of the 516 potentially relevant studies were assessed rigorously, and a total of 472 studies were then excluded. Finally, 44 studies were included in the meta- 
Study characteristics and quality evaluation
A total of 44 case-control studies, covering 19 provinces (or municipalities) nationwide, were included in this metaanalysis. Of these studies, 12 [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] were published during the ten years before 2008, involving 3436 cases and 4157 controls; 32 studies were published during the ten years after 2008, involving 10341 cases and 14289 controls.
All of these studies were published in Chinese except for 2 studies published in English. After quality assessment by the Newcastle-Ottawa Scale, 15 studies got a score of 5, 21 studies got a score of 6, and 7 studies got a score of 7, 1 study got a score of 8. The main characteristics of the included studies are showed in Table 1 . 
Exposure to chemical toxic substances during pregnancy
Six studies assessed exposure to chemical toxic substances (such as pesticides, organic solvents, etc.) during pregnancy as a possible risk factor. No evidence of heterogeneity was found (p=0.248, I 2 =24.8%), thus a fixed effect model was conducted. The overall results of this meta-analysis showed that exposure to chemical toxic substances during pregnancy significantly increased the risk of CHD (OR=4.67, 95%CI: 3.44-6.34, p<0.001, Figure 2b ). No obvious change was found in sensitivity analysis, suggesting the results were stable.
Negative life events during pregnancy
Six studies explored the association between negative life events during pregnancy and the risk of CHD. 
Medication use during pregnancy
Five studies reported the association between medication use during pregnancy and the risk of CHD. No evidence of heterogeneity was found (p=0.182, I 2 =35.8%), therefore a fixed effect model was used. The overall results of this metaanalysis showed that medication use during pregnancy significantly increased the risk of CHD (OR=2.10, 95%CI:
1.60-2.76, p<0.001, Figure 2d ). No obvious change was found in sensitivity analysis, indicating the results were stable.
Infection during pregnancy
Four studies assessed the association between infection during pregnancy and the risk of CHD. Figure 2e ). No significant change was found in sensitivity analysis, suggesting the results were stable.
Abnormal childbearing history
Three studies assessed the association between abnormal childbearing history (such as abortion, stillbirth, etc.) and the risk of CHD. No evidence of heterogeneity was found (p=0.320, I 2 =12.2%), therefore a fixed effect model was used.
The overall results of this meta-analysis showed that abnormal childbearing history significantly increased the risk of CHD (OR=1.73, 95%CI: 1.28-2.34, p<0.001, Figure 2f ). No significant change was found in sensitivity analysis, suggesting the results were stable. The same risk factors as ten years before 2008
Colds during pregnancy
Sixteen of the 32 studies investigated colds during pregnancy as a potential risk factor for the onset of CHD. As there was heterogeneity between the 16 studies (p<0.001, I
2 =85.2%), a random effect model was adopted. The overall results of this meta-analysis showed that colds during pregnancy significantly increased the risk of CHD (OR=2.75, 95%CI:
1.97-3.83, p<0.001, Figure 3a) . To explore the source of heterogeneity, meta regression analyses were conducted based on year of publication, quality of study, geographical region and number of cases. However, no significant results were derived. No significant change was found in sensitivity analysis, suggesting the results were stable. No publication bias was found in this meta-analysis (Egger's test p=0.870).
Exposure to chemical toxic substances during pregnancy
Thirteen studies assessed exposure to chemical toxic substances during pregnancy as a possible risk factor. As there was heterogeneity between the 13 studies (p<0.001, I 2 =86.2%), a random effect model was adopted. The overall results of this meta-analysis showed that exposure to chemical toxic substances during pregnancy significantly increased the risk of CHD (OR=3.43, 95% CI: 2.05-5.74, p<0.001, Figure 3b ). To explore the source of heterogeneity, meta regression analyses were conducted and number of cases was found to be the possible source (p=0.018). Subgroup analysis by number of cases was further performed, in the subgroup of cases ≤ 200, the pooled OR was 2.13 (95% CI: 
Negative life events during pregnancy
Five studies explored the association between negative life events during pregnancy and the risk of CHD. Figure 3d ). No publication bias was found in this meta-analysis (Egger's test p=0.557). No obvious change was found in sensitivity analysis, indicating the results were stable.
Infection during pregnancy
Four studies assessed the association between infection during pregnancy and the risk of CHD. Figure 3e ). No significant change was found in sensitivity analysis, suggesting the results were stable.
Abnormal childbearing history
Four studies assessed the association between abnormal childbearing history and the risk of CHD. Figure 3f ). No significant change was found in sensitivity analysis, suggesting the results were stable. 
Periconceptional folic acid supplementation
Nine studies assessed the association between periconceptional folic acid supplementation and the risk of CHD. No 
Living or working near factories during pregnancy
Six studies assessed the association between living or working near factories during pregnancy and the risk of CHD.
No evidence of heterogeneity was found (p=0.153, I 2 =38.0%), therefore a fixed effect model was adopted. The overall results of this meta-analysis showed that living or working near factories during pregnancy significantly increased the risk of CHD (OR=2.10, 95%CI: 1.64-2.69, p<0.001, Figure 4d ). No significant change was found in sensitivity analysis, indicating the results were stable.
Living in newly renovated rooms during pregnancy
Six studies explored the association between living in newly renovated rooms during pregnancy and the risk of CHD.
As there was heterogeneity between the 6 studies (p<0.001, I 2 =81.0%), a random effect model was used. The overall Although the clear biological mechanisms underlying the relationship between these risk factors and the onset of CHD remain to be determined, some relevant hypotheses have been proposed. Living in newly renovated rooms, living or working near factories, living near major traffic roads, exposure to chemical toxic substances, as well as passive smoking during pregnancy, all of them will expose pregnant women to environmental teratogens such as formaldehyde, benzene, organic solvents, heavy metals, carbon monoxide, ozone, pesticides, herbicides, and cigarette smoke etc., which may induce congenital malformations through the induction of oxidative stress [36, 51] . As for infections and colds during pregnancy, many pathogens of infections and colds could be transmitted vertically to fetus through placenta and increase the risk of congenital malformations. In addition, fever caused by infections and colds may lead to abnormal cell apoptosis during embryonic heart development and hence cause cardiac dysplasia [52] [53] [54] [55] .
The possible mechanism between medication use during pregnancy and CHD risk may be that, many medications have the ability to cross placental and blood-brain barriers, which may directly affect embryonic development and increase the risk of congenital malformations [56, 57] . Maternal stress caused by negative life events during pregnancy would lead to increased secretion of plasma adrenocorticotrophin, β-endorphin, glucocorticoids, and catecholamines, which may lead to changes in the fetal neurotransmitter systems and transcriptional mechanisms [40, 58] . Abnormal childbearing history, such as previous abortions, may result in some residual effects that may affect the development of subsequent embryo [59, 60] . In addition, the causes of previous abnormal pregnancies, such as genetic factors, uterine factors, maternal chronic diseases, etc., if not removed, will still affect subsequent embryonic development [60] .
Moreover, having an abnormal childbearing history may lead to an increased use of medications, which may increase the possibility of congenital malformations induced by medications [36] . Periconceptional folic acid supplementation was found as an protective factor for CHD. It has been hypothesized that deficiency of folic acid during pregnancy would impair folate and/or homocysteine metabolism, result in hyperhomocysteinemia and impair methionine formation in the embryo, which may increase the risk of congenital malformations [2, 3, [60] [61] [62] . Periconceptional vitamin supplementation was another protective factor for CHD. Many vitamins play important roles during embryonic development. For example, vitamin B 12 works as a coenzyme with folates in methionine, purine, and thymine synthesis, and one-carbon metabolism, vitamin C may protect embryos from oxygen free radical damages due to their antioxidant properties [62, 63] .
There are some limitations in this meta-analysis. Firstly, all the 44 studies included in the final meta-analysis were case-control studies, which were susceptible to selection bias and information bias. Therefore, we evaluated the quality of each eligible study rigorously and eliminated studies with poor quality to increase the credibility of our results.
Secondly, although significant heterogeneity were found in negative life events during pregnancy (the ten years before 2008), passive smoking during pregnancy, and living in newly renovated rooms during pregnancy, we did not carry out further analysis to clarify the source of heterogeneity due to the lack of enough studies. Thirdly, there were limited evidence regarding these newly emerged factors such as living near major traffic roads (<50m) during pregnancy, living in newly renovated rooms during pregnancy, etc., thus only several studies were included in our meta-analysis to explore the association between these new factors and the risk of CHD. Therefore, further studies should focus on these new risk factors, rather than those for which considerable evidence already exists.
Despite the limitations mentioned above, there are also some strengths in this meta-analysis. Firstly, to our best knowledge, this is the first meta-analysis comparing the major maternal risk factors of CHD in Chinese population between the ten years before 2008 and the ten years after 2008. And 6 new risk factors, focusing on the living environments, lifestyles, and health care during pregnancy, were further identified in this meta-analysis. Secondly, this meta-analysis covered a total of 12 risk factors of the onset of CHD, and each of them was analyzed carefully in our paper.
Conclusions
The major maternal risk factors of CHD in Chinese population has changed greatly between the ten years before 2008 and the ten years after 2008. And a total of 12 factors were identified as the current risk factors of CHD in Chinese population. Among these two periods, there are 6 same risk factors and 6 newly emerged risk factors of CHD. Of the 6 same risk factors, the OR value of infection during pregnancy has significantly changed, which may be due to the
